A Daubert motion: A legal strategy to exclude essential scientific evidence in toxic tort litigation

American Journal of Public Health

Volumn 95, Issue SUPPL. 1, 2005, Pages

  Melnick, Ronald L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COURT; DATA ANALYSIS; DECISION MAKING; ENVIRONMENTAL FACTOR; EXPERT WITNESS; LAW SUIT; METHODOLOGY; QUALITY CONTROL; SCIENCE;

CAUSALITY; DRUG INDUSTRY; ENVIRONMENTAL EXPOSURE; EXPERT TESTIMONY; GOVERNMENT REGULATION; HUMANS; JUDICIAL ROLE; LIABILITY, LEGAL; PUBLIC POLICY; SCIENCE; SUPREME COURT DECISIONS; UNCERTAINTY; UNITED STATES;

EID: 22744439588     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2004.046250     Document Type: Article

References (32)

1. Daubert v Merrell Dow Pharmaceuticals, Inc, 509 US 579 (1993).
2. Cranor C. Scientific inferences in the laboratory and the law. Am J Public Health. 2005;95:S121-S128.
3. Wagner W. The perils of relying on interested parties to evaluate scientific quality. Am J Public Health. 2005; 95S99-S106.
4. Cecil JS. Ten years of judicial gate-keeping under Daubert. Am J Public Health. 2005;95:S74-S80
5. Jasanoff S. Law's knowledge: science for justice in legal settings. Am J Public Health. 2005;95:S49-S58.
6. Haack S. Trial and error: the Supreme Court's philosophy of science. Am J Public Health. 2005;95:S66-S73.
7. International Agency for Research on Cancer. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risks Hum. 2002;82:1-556.
8. Huff J. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. Int J Occup Environ Health. 2002;8:249-270.
9. Berger MA. What has a decade of Daubert wrought? Am J Public Health. 2005;95:S59-S65.
10. Tomatis L, Melnick RL, Haseman J, Barrett JC, Huff J. Alleged 'misconceptions' distort perceptions of environmental cancer risks. FASEB J. 2001;15: 195-203.
11. Lakoff G. A cognitive scientist looks at Daubert. Am J Public Health. 2005;95:S114-S120.
12. Melnick RL. Carcinogenicity and mechanistic insights on the behavior of epoxides and epoxide-forming chemicals. Ann N Y Acad Sci. 2002;982: 177-189.
13. International Agency for Research on Cancer. 2,3,7,8- Tetrachlorodibenzopara-dioxin. IARC Monogr Eval Carcinog Risks Hum. 1997;69:33-343.
14. International Agency for Research on Cancer. Ethylene oxide. IARC Monogr Eval Carcinog Risks Hum 1994; 60:73-159.
15. National Toxicology Program. Report on Carcinogens. Carcinogen Profiles 2002. 10th ed. Research Triangle Park, NC: US Department of Health and Human Services; 2002.
16. Krimsky S. The weight of scientific evidence in policy and law. Am J Public Health. 2005;95:S129-S136.
17. Tomatis L, Huff J, Hertz-Picciotto I, et al. Avoided and avoidable risks of cancer. Cardnogenesis. 1997;18: 97-105.
18. Moure-Eraso R. Primary prevention and precaution in hazard identification in the N1EHS/NTP: body in the morgue approach. Public Health Rep. 2002;117:564-573.
19. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
20. Huff J. Chemicals and cancer in humans: first evidence in experimental animals. Environ Health Perspect. 1993; 100:201-210.
21. Occupational Safety and Health Administration. Occupational exposure to 1,3-butadiene; Final rule. Fed Reg. 1996;61:56746-56856.
22. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser. 1984; 288:1-111.
23. Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science. 1985; 227:548-549.
24. Macaluso M, Larson R, Delzell E, et al. Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology. 1996;113: 190-202.
25. Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of 1,3-butadiene in C57BL/6 × C3H F1 mice at low exposure concentrations. Cancer Res. 1990; 50:6592-6599.
26. Greenland S. Relation of probability of causation to relative risk and doubling dose: a methodologic error that has become a social problem. Am J Public Health. 1999;89:1166-1169.
27. Hayes T, Haston K, Tsui M, Hoang A, Haeffele C, Vonk A. Herbicides: feminizantion of male frogs in the wild. Nature. 2002;419:895-896.
28. Hayes TB, Collins A, Lee M, et al. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses. Proc Natl Acad Sci USA. 2002;99: 5476-5480.
29. Sass J, Devine J. The Center for Regulatory Effectiveness invokes the Data Quality Act to reject published studies on atrazine toxicity. Environ Health Perspect. 2004;112:A18.
30. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disrupters: a report of the US EPA-sponsored workshop. Environ Health Perspect. 1996;104(suppl 4): 715-740.
31. Stoker TE, Laws SC, Guidici DL, Cooper RL. The effect of atrazine on puberty in male Wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function. Toxicol Sci. 2000;58:50-59.
32. Friedmann AS. Atrazine inhibition of testosterone production in rat males following peripubertal exposure. Reprod Toxicol. 2002;16:275-279.